★ Daily Intelligence Briefings (DIBs)MarketsPolitics & Policy Cannabis Valuations Crumbling on Weaker Revenues, Lack of Congressional Action on Federal Reforms Cannabis is becoming much more popular than alcohol among younger cohorts of the US population and regulated sales of marijuana…McAlinden Research PartnersJune 13, 2022
★ Daily Intelligence Briefings (DIBs)Politics & PolicyServices Cannabis Stocks Continue to Slide, Sector Struggles to Overcome Legislative Deadlock Shares of most major cannabis firms have plummeted year to date. This continuation of a downtrend that began in the…McAlinden Research PartnersApril 19, 2022
★ Daily Intelligence Briefings (DIBs)⦁ Theme TrackerMarketsPolitics & PolicyServices Cannabis Earnings Impress, Slow Pace of Regulatory Reform Could Accelerate in Months Ahead Publicly-traded cannabis firms' breakout sales growth has largely decoupled from the underperformance of their underlying stock prices over the last month.…McAlinden Research PartnersAugust 31, 2021
★ Daily Intelligence Briefings (DIBs)⦁ Theme TrackerMarketsPolitics & PolicyServices US Cannabis Sales Hold Strong as Industry Lays Out New Lobbying Efforts to Expedite Federal Reform Among the 37 US states that have legalized the distribution of medicinal marijuana, 19 allow the recreational use of cannabis.…McAlinden Research PartnersJune 30, 2021